Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Companies / P••••••••• T••••••••• I•••

P••••••••• T••••••••• I•••

Stage unknownSeattle, WABiotechnology
Facts
Year of incorporation
unknown
Revenue range (Form D)
Decline to Disclosesec.gov
Rounds on record
2
Disclosed raised
unknownsum of rounds with a disclosed amount only
Named investors
0
Financing history
2 rounds
  1. Mar 4, 2024
    Form D equity offering · $87.4M (form d sold) · 9 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “P••••••••• T••••••••• I••• filed Form D: $87,409,482 sold of $87,409,482, Biotechnology”
  2. Jan 8, 2024
    Form D equity offering · $20.8M (form d sold) · 1 investors
    Fact SEC EDGAR Form D data sets (quarterly) · “P••••••••• T••••••••• I••• filed Form D: $20,846,671 sold of $20,846,671, Biotechnology”
Investors on record
0 edges
No named investor yet.
People
4 officers, 4 directors
Timeline
2
  1. Mar 18, 2024
    P••••••••• T••••••••• I••• filed Form D: $87,409,482 sold of $87,409,482, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
  2. Jan 22, 2024
    P••••••••• T••••••••• I••• filed Form D: $20,846,671 sold of $20,846,671, Biotechnology
    Form D filed Fact SEC EDGAR Form D data sets (quarterly)
Evidence
28 observations
Every observation on this company